EEA1 (C45B10)

ANTIBODY monoclonal C45B10 manufacturer Cat# 3288 Immunogen = synthetic peptide corresp. to residues surrounding Ser70 of human EEA1 protein liquid, HEPES, saline, BSA, glycerol, azide detects endogenous levels of total EEA1 protein IgG Protein Trafficking Cell Si

EEA1

ANTIBODY polyclonal manufacturer Cat# 2411<br />Reference: <br />(unspecified clonality,<br /><a href="/papers/macroautophagy-not-directly-involved-metabolism-amyloid-precursor-protein" target="_new">Boland, 2010</a&g

MAP1 LC3A (D50G8)

ANTIBODY monoclonal D50G8 manufacturer Cat# 4599 Immunogen = synthetic peptide corresp. to residues near the amino terminus of LC3A liquid, HEPES, saline, glycerol, azide detects endogenous levels of total LC3A protein Cross-reactivity occur with LC3B expect monke

MAP1 LC3B (D11)

ANTIBODY monoclonal D11 manufacturer Cat# 3868 Immunogen = synthetic peptide corresp. to residues near the amino terminus of LC3B liquid, HEPES, saline, glycerol, azide detects endogenous levels of total LC3B protein. Cross-reactivity occur with other LC3 isoforms

Kay Gray on Multilingualism (but not always bilingualism) delays the onset of Alzheimer disease: evidence from a bilingual community.

COMMENT How do the authors distinguish between French/English bilinguals and French-Canadian ancestry? In other words, how did they determine that they are not finding a lower incidence of Alzheimer's among people with a French-Canadian genetic background? 0

MAP1 LC3A/B

ANTIBODY polyclonal manufacturer Cat# 4108<br />Reference: <br /><a href="/papers/macroautophagy-not-directly-involved-metabolism-amyloid-precursor-protein" target="_new">Boland, 2010</a> Immunogen = synthetic peptide co

Aβ42, murine

ANTIBODY monoclonal laboratory JRF/rAβ/2 <br />(<a href="http://www.med.nyu.edu/research/mathep01.html" target="_new">Paul Mathews</a>, New York University, School of Medicine,<br /><a href="http://cdr.rfmh.org/p

Hemanth Kandikattu

India

Louis De Muynck

Belgium

Haung Yu

Centre for Addiction and Mental Health
Toronto, Canada

MAP1 light chain LC3 (2G6)

ANTIBODY monoclonal 2G6 manufacturer Cat# 0260-100/LC3-2G6 immunogen = synthetic peptide conjugated to hemocyanin (epitope at N-Terminus of LC3-B) liquid recognizes MAP1 light chain component LC-3 others not tested IgG₁ MAPs nanoTools Antikö

Tae-kyung Park

Kay Gray

United States

Diane Owen

United States

PAPER Cookson MR

The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease.

Nat Rev Neurosci. 2010 Dec;11(12):791-7. Epub 2010 Nov 19 PubMed: 21088684